Foxorox AI Market Research
Vertical software, acquisition economics, AI disruption and relative valuation.
Research date: September 26, 2026. Financial results: Q2 2026.
Market valuation figures are dated snapshots, not live quotes.
Foxorox bearish trend: The bearish designation is the current user-reported Foxorox signal. No numerical probability or gap estimate has been supplied for ROP; none is invented here.
Is AI Starting to Threaten Roper Technologies' Business Model?
We think there is a much bigger question surrounding Roper Technologies than its latest earnings or current share price: What happens to its business when AI agents start doing the work that customers currently pay Roper's software to perform? Multitask delivered by AI agents is much more efficent than Roper human service and Roper software.
Roper owns a portfolio of specialized software businesses, including Deltek, Aderant, Vertafore, DAT and CentralReach. These companies operate in industries where customers depend on their software for everyday operations. Historically, that has been an attractive business model. Customers pay recurring subscription fees, switching providers is difficult, and Roper benefits from predictable revenue.
But AI agents could change those economics. Imagine a company that currently pays for 100 software licenses. If AI agents can perform much of the work previously handled by employees, will that company still need 100 licenses? Or will it eventually need just 20 licenses and a handful of AI agents? It is obvious that cost of people is higher then AI agents. There is another possibility. Customers might continue using Roper's software to store and manage their data while relying on external AI agents to perform the actual work. In that scenario, Roper could retain its customers but lose some of its pricing power and opportunities to sell additional software. This raises three important questions: 1. Will customers start reducing their traditional software subscriptions while continuing to use Roper's platforms primarily as databases? 2. Will the additional revenue generated by Roper's own AI agents be enough to compensate for potential losses in traditional software subscriptions? 3. What happens if independent AI providers gain access to the data and workflows that currently give Roper its competitive advantage? These questions are particularly relevant to businesses such as Deltek, Aderant and Vertafore, where AI agents could automate administrative work, reporting, document processing and other tasks that currently require human interaction with specialized software. However, there is an important distinction between a potential threat and something that is already happening. During a September 2026 Goldman Sachs conference, Roper's CEO, Neil Hunn, addressed concerns about AI reducing the number of paid software users. According to management, the company has not yet observed a significant decline in customer subscriptions attributable to AI, and enterprise customer retention remains around 95%. Roper is also developing its own AI products. The company intends to introduce additional subscription packages and usage-based pricing, allowing customers to pay for work performed by AI agents. In other words, Roper is trying to benefit from the same technological shift that could threaten its existing business. The problem is that this transition is still in its early stages. Roper's second-quarter 2026 results showed approximately 9% revenue growth, but organic growth was only around 5%. Adjusted earnings and free cash flow continued to increase. These figures do not demonstrate that AI is already causing customers to abandon Roper's software. Nevertheless, investors may be concerned about what happens over the next several years rather than what happened in the latest quarter. My main concern is that Roper could continue reporting respectable financial results while the long-term economics of some of its software businesses gradually deteriorate. A customer does not necessarily have to abandon Roper's software for AI to become a problem. Simply reducing the number of paid users, negotiating lower subscription fees or moving additional functionality to external AI providers could affect future revenue growth. That is why I believe the market's concerns deserve attention, even though there is currently insufficient evidence to conclude that AI is responsible for Roper's declining share price. The next few quarters should provide more information. I would pay particular attention to organic subscription growth, customer retention, revenue generated by new AI products and any changes in how Roper charges customers for its software. The central question is no longer whether Roper can develop AI agents. It is whether Roper can capture enough of the economic value created by those agents to protect its existing business model.Recent price drop we assume as mkts estimates that Roper would have harsh time as more and more AI agents delivers more then softoware from Roper.
Daily candles. Roper is shown alongside three listed vertical-software/data-software peers. These are business-model comparisons, not identical product-market competitors.
Roper is not a conventional industrial conglomerate anymore. It is primarily a portfolio of niche, mission-critical software and technology businesses acquired and managed for long-term free cash flow per share.
Yet its shares have suffered a major valuation reset. The important distinction: operating performance is not collapsing, but the market has become less willing to capitalize software cash flows at historical premium multiples.
The central question: Is the falling stock signaling deterioration in Roper's economic moat, or is the market repricing a still-profitable acquisition-driven software portfolio because of AI, organic-growth expectations and capital allocation risk?
Roper operates across three reporting segments. Application Software includes mission-critical vertical software for healthcare, education, insurance, legal and project-based businesses. Network Software includes transaction-oriented platforms and industry networks such as freight matching. Technology Enabled Products includes specialized measurement and medical technology products.
| Segment | Q2 2026 revenue | Share of total | Business model |
|---|---|---|---|
| Application Software | $1,180.8M | 56.0% | Vertical applications, recurring software |
| Network Software | $430.9M | 20.4% | Industry networks, software and transactions |
| Technology Enabled Products | $497.2M | 23.6% | Specialized medical and industrial products |
| Total | $2,108.9M | 100% | Hybrid software / technology portfolio |
Approximately three-quarters of revenue now comes from the two software segments. That is why comparing Roper only with industrial conglomerates would be misleading.
| Metric | Q2 2026 | Year-on-year change |
|---|---|---|
| Revenue | $2.109B | +8.5% reported |
| Organic revenue | — | +4.9% exact / ~5% rounded |
| Acquisition contribution | — | +3.4 percentage points |
| Adjusted EBITDA | $815M | ~+5% |
| Adjusted EBITDA margin | 38.6% | Core margin -70 bps |
| Adjusted diluted EPS | $5.38 | +10% |
| GAAP diluted EPS | $11.62 | +233%; not representative of recurring EPS |
| Adjusted free cash flow | $447M | +11% |
| TTM adjusted free cash flow | $2.565B | +11% |
The revenue and cash-flow figures are healthy. However, EBITDA growth lagged revenue growth, and the reported 233% GAAP EPS jump must not be confused with the 10% increase in adjusted EPS.
Roper's Q2 growth was approximately 8.5%, but underlying organic growth was 4.9%. Acquisitions contributed 3.4 percentage points, with a small currency contribution.
| Growth component | Contribution |
|---|---|
| Reported growth | 8.5% |
| Acquisitions | 3.4 percentage points |
| Currency | 0.2 percentage points |
| Organic growth | 4.9% |
The company is growing, but almost 40% of the quarter's reported percentage growth came from acquisitions. Investors must distinguish acquired revenue from improvements in the existing businesses.
| Segment | Reported growth | Organic growth | Operating margin Q2'25 → Q2'26 |
|---|---|---|---|
| Application Software | 7.8% | 4.5% | 26.9% → 27.4% |
| Network Software | 11.8% | 3.6% | 43.9% → 41.0% |
| Technology Enabled Products | 7.3% | 7.1% | 35.4% → 33.3% |
The clearest operational concern is not the consolidated revenue line. It is the combination of modest organic growth in Network Software and margin compression in two of the three reporting segments.
Network Software reported 11.8% revenue growth but only 3.6% organic growth. The difference was driven largely by acquired businesses, including Subsplash. Operating margin fell by 290 basis points, from 43.9% to 41.0%.
The company identified acquisition-related expense profiles and revenue mix, including payments and freight-related platform activities. These may be manageable, but they challenge the idea that every additional dollar of acquired revenue immediately preserves historical margins.
Technology Enabled Products grew organically by 7.1%, helped by medical products. Yet its gross margin fell from 58.6% to 56.9%, while operating margin fell from 35.4% to 33.3%.
Roper attributed pressure to higher input costs at Neptune, product mix at NDI and Verathon, and weaker operating leverage in water-meter technology. This is a real operating issue, not merely market speculation.
Roper argues that its proprietary data, domain expertise, installed customer relationships and mission-critical workflows create a foundation for differentiated AI products. Management reported multiple new AI product launches in Q2 and discussed commercialization through new subscription offerings.
However, investors are also reassessing the durability of traditional software economics. AI can accelerate software development, reduce implementation barriers, change user interfaces and put pressure on vendors that sell narrowly defined workflow functionality.
This is an industry risk scenario, not evidence that Roper has already lost customers to AI competitors.
Some portfolio businesses are exposed to customers' spending cycles. Government contracting software can be sensitive to procurement delays and uncertainty; freight matching is influenced by trucking volumes and spot-market activity.
Management has discussed earlier headwinds in Deltek's government-contracting market and DAT's freight market, although freight indicators showed signs of improvement in 2026.
The portfolio is diversified, but it is not immune to the real economy or government spending timing.
Roper's historical strategy is to acquire specialized businesses with durable market positions and attractive cash generation. Acquisitions such as CentralReach, Orchard Software and Subsplash contributed to recent reported growth.
The economic challenge is to generate returns above the cost of acquisition capital without compromising organic growth or margins.
With acquisition-driven businesses, investors should track free cash flow per share, return on invested capital, net debt and organic growth together. EPS growth alone is insufficient.
Roper repurchased 3.6 million shares for $1.2 billion in Q2. Cumulative repurchases over three quarters reached 9 million shares for $3.2 billion — more than 8% of shares outstanding, according to management.
| Measure | Amount |
|---|---|
| Q2 repurchases | $1.2B |
| Q2 shares repurchased | 3.6M |
| Three-quarter cumulative repurchases | $3.2B |
| Cumulative shares | 9.0M |
| Approx. average cumulative purchase price | $356/share |
The cumulative average is calculated as $3.2B / 9M shares. Buybacks improve per-share results when executed at attractive prices, but cannot permanently offset slowing organic growth or lower acquisition returns.
| Metric | Prior guidance | Revised July 2026 |
|---|---|---|
| Adjusted diluted EPS | $21.80–$22.05 | $22.15–$22.30 |
| Total revenue growth | ~8% | 8%+ |
| Organic growth | 5–6% | ~6% |
| Q3 adjusted EPS | — | $5.75–$5.80 |
This is essential context. The latest published earnings release does not show a business issuing a profit warning. The stock's decline needs to be understood through expectations, valuation and the composition of growth.
Roper's pending Indicor instrumentation divestiture was expected to generate approximately $1.1 billion in after-tax proceeds, increasing acquisition capacity.
Management indicated more than $5 billion of potential capital deployment capacity. The opportunity is significant, but the quality, price and timing of future deals remain central to the investment case.
Roper's reported GAAP earnings include gains and other items that can materially distort trailing P/E. Therefore a screen displaying a trailing P/E around 15x should not be interpreted as 15x recurring earnings.
The more useful starting point is management's full-year adjusted EPS guidance, while remembering that adjusted EPS also excludes costs such as acquired-intangible amortization.
Market data from September 22, 2026 indicated approximately $35.99B market capitalization and $46.94B enterprise value. The figures below are indicative and may differ from later trading prices.
| Metric | Value | Interpretation |
|---|---|---|
| Market capitalization | ~$35.99B | Equity value snapshot |
| Enterprise value | ~$46.94B | Includes net financial obligations and other EV adjustments |
| Reported trailing P/E on quote screen | ~15.2x | Distorted by nonrecurring GAAP earnings |
| EV / revenue (quoted) | ~5.67x | Relatively high for a traditional industrial, different for software |
| EV / EBITDA (quoted) | ~10.94x | Check data vendor's EBITDA definition and period |
| TTM adjusted FCF | $2.565B | Company non-GAAP measure |
| Equity / adjusted FCF | ~14.0x | $35.99B / $2.565B; illustrative, not normalized forecast |
| Adjusted FCF yield | ~7.13% | $2.565B / $35.99B |
For consistency, valuation comparisons should use the same measurement date, fiscal periods and adjustment definitions. An apparent discount based only on a quote-provider P/E may be illusory.
Using management's revised midpoint of $22.225 adjusted diluted EPS, the following is a simple price sensitivity table, not a forecast.
| Illustrative share price | 2026 adjusted P/E | Adjusted earnings yield |
|---|---|---|
| $300 | 13.5x | 7.41% |
| $350 | 15.7x | 6.35% |
| $375 | 16.9x | 5.93% |
| $400 | 18.0x | 5.56% |
| $450 | 20.2x | 4.94% |
| $500 | 22.5x | 4.45% |
At a hypothetical $375 share price, Roper would trade at approximately 16.9x management's adjusted 2026 EPS guidance. Whether that is attractive depends on organic growth, acquisition returns, leverage and how much of the adjusted earnings translates into sustainable owner cash flow.
| Company | Ticker | Business overlap | Key difference |
|---|---|---|---|
| Roper Technologies | ROP | Vertical software, data, specialist products | Acquisition-led multi-business portfolio |
| Tyler Technologies | TYL | Mission-critical public-sector software | Concentrated government-software model |
| Verisk Analytics | VRSK | Proprietary data and insurance workflows | More focused insurance-data platform |
| Veeva Systems | VEEV | Regulated vertical cloud software | Life-sciences concentration; different balance sheet |
These peers are intentionally selected for vertical software and proprietary-data economics. They are not exact substitutes for every Roper segment. A pure multiple comparison without accounting for Roper's product exposure, M&A strategy and leverage would be incomplete.
| Indicator | Roper | Tyler | Verisk | Veeva |
|---|---|---|---|---|
| Core exposure | Multi-vertical software + products | Government software | Insurance data/software | Life-sciences cloud |
| Organic growth sensitivity | Portfolio average | Cloud transition / government budgets | Insurance volumes and analytics demand | R&D and commercial life-sciences spend |
| Acquisition dependence | Material | Lower relative strategic emphasis | More focused portfolio | Primarily platform-led growth |
| Balance-sheet consideration | Acquisition debt matters | Review net debt | Review net debt and buybacks | Different cash/debt profile |
| AI opportunity | Domain-specific workflow agents | Public-sector automation | Data-driven insurance analytics | Life-sciences workflows |
| AI disruption risk | Varies widely by subsidiary | Mission-critical public systems | Proprietary datasets provide differentiation | Regulated workflows and platform competition |
| Comparable valuation measure | Normalized EV/EBITDA + FCF/share | Forward EV/FCF + growth | Forward EV/FCF + growth | Forward earnings/FCF with net cash adjustment |
A same-date numerical peer-multiple table has intentionally not been fabricated: the available public snapshots do not provide consistent September 2026 normalized forward EBITDA and FCF figures for all four businesses. Use the live charts above for price comparison and a single synchronized consensus source before publishing precise cross-company multiples.
| Potential premium factor | Potential discount factor |
|---|---|
| Mission-critical software and high switching costs | Portfolio complexity and reduced transparency |
| Proprietary vertical data | Slower organic growth than headline growth |
| Recurring cash generation | Acquisition execution and financing risk |
| Strong cash-flow conversion | Margin compression in some segments |
| AI monetization opportunities | AI disruption fears and valuation reset |
The following scenarios apply illustrative adjusted P/E multiples to management's $22.225 midpoint guidance. They are sensitivity calculations, not price targets or predicted outcomes.
| Assumed adjusted P/E | Implied illustrative equity value per share | Required interpretation |
|---|---|---|
| 13x | ~$289 | Persistent discount for growth and AI concerns |
| 16x | ~$356 | Moderate adjusted-earnings valuation |
| 19x | ~$422 | Greater confidence in portfolio durability |
| 22x | ~$489 | Renewed premium for compounding and AI execution |
Because this model uses adjusted EPS, investors should separately examine acquired-intangible amortization, debt and free cash flow before relying on it.
Roper's falling share price should not be mistaken for collapsing fundamentals. The company increased 2026 guidance, generated $447 million of adjusted quarterly free cash flow and continued substantial repurchases. At the same time, organic growth is materially below reported growth, two segment margins declined, and the acquisition-led model must prove its resilience in a changing AI software market.
Foxorox currently identifies a bearish trend. Fundamental analysis explains why the stock can remain under pressure even when quarterly earnings are positive: the market is reassessing the premium previously paid for predictable vertical-software compounding.
The decisive variables are future organic growth, margin recovery, AI monetization and cash-flow returns on capital deployment.
Written by Pawel Demczuk, MSc
Foxorox AI Analyzer
Roper Technologies — Q2 2026 earnings release
SEC — Roper Q2 2026 Form 10-Q
Roper Q2 2026 investor presentation
Yahoo Finance — ROP market snapshot and valuation
Roper investor relations — latest announcements
GAAP and adjusted metrics are distinguished throughout. Calculated valuation sensitivities are illustrative. Market values and vendor multiples can change daily. TradingView widgets require external scripts to be permitted by the blog host. The Foxorox signal is user-provided and has not been independently recalculated. Informational research, not personalized investment advice.